COST
57
-6
DHR
32
-6
CAH
48
-6
CB
57
2
PCAR
56
-5
PBI
56
-2
CMA
61
-3
PSA
56
3
ADM
28
3
AVGO
18
-9
MSI
72
-3
WAT
48
-11
NOV
52
-5
JWN
48
-2
FE
44
5
AIV
64
4
RCL
83
-2
BDX
56
10
WM
74
-5
ICE
59
-3
COST
57
-6
DHR
32
-6
CAH
48
-6
CB
57
2
PCAR
56
-5
PBI
56
-2
CMA
61
-3
PSA
56
3
ADM
28
3
AVGO
18
-9
MSI
72
-3
WAT
48
-11
NOV
52
-5
JWN
48
-2
FE
44
5
AIV
64
4
RCL
83
-2
BDX
56
10
WM
74
-5
ICE
59
-3
Financhill
Back

Thornburg Income Builder Opportunities Trust Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
31

TBLD
Thornburg Income Builder Opportunities Trust

Last Price:
16.58
Seasonality Move:
3.69%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
31
Thornburg Income Builder Opportunities Trust (TBLD) is a Sell

Is Thornburg Income Builder Opportunities Trust a Buy, Sell or Hold?

  • The current Thornburg Income Builder Opportunities Trust [TBLD] share price is $16.56. The Score for TBLD is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • TBLD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TBLD Stock Price Chart

What is Thornburg Income Builder Opportunities Trust's stock price today?

  • The Thornburg Income Builder Opportunities Trust share price today is $16.56
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TBLD is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

TBLD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 34.41 Sell
Chaikin Money Flow: 1965 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.88 - 17.4) Sell
Bollinger Bands (100): (16.46 - 17.42) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

TBLD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.85 Sell
20-day SMA: 17.08 Sell
50-day SMA: 17.31 Sell
200-day SMA: 16.4 Buy
8-day EMA: 16.8 Sell
20-day EMA: 17.01 Sell
50-day EMA: 17.11 Sell
200-day EMA: 16.5 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Thornburg Income Builder Opportunities Trust Earnings Growth & TBLD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Thornburg Income Builder Opportunities Trust Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):